Johnson & Johnson today announced that the company has submitted the OTTAVA™ Robotic Surgical System to the U.S. Food and Drug Administration (FDA) in an application for De Novo classification.
In summer 2024, the Biden administration proposed a rule to improve free, unfettered data sharing between health insurers, providers and public health organizations by certifying the health IT ...
Migration of 732,000 policies to DXC Assure Platform delivers 22 percent lower operating costs, four new products, and a more scalable cloud foundation This first phase of ivari's digital ...
ALBANY, N.Y. — The New York State Department of Motor Vehicles is overhauling the point system it uses to penalize drivers and the changes could impact you significantly. The new system has already ...
Learn about the rules and cost-effective ways to combine multiple policies to meet changing life insurance insurance needs Written By Written by Insurance Staff Writer, WSJ | Buy Side Kimberly ...
WASHINGTON, Nov 20 (Reuters) - U.S. officials will consider enforcement of affirmative action policies and state subsidies for abortion as infringements when compiling the State Department’s annual ...
SAN FRANCISCO, Nov. 14, 2025 /PRNewswire/ -- Docusign (DOCU), the Intelligent Agreement Management platform company, today announced it has been named as a Leader in the 2025 Gartner Magic Quadrant ...
REDWOOD CITY, Calif., Nov. 14, 2025 /PRNewswire/ -- Agiloft, a leader in data-first contract lifecycle management (CLM), announced today that it has been named a Leader in the Gartner Magic Quadrant ...
WASHINGTON–The Supreme Court of the United States today granted a request from the Trump administration to stay a preliminary injunction in Orr v. Trump, allowing the government to enforce a ...
A $1 million policy might be more affordable than you think Written By Written by Insurance Writer, Buy Side John is a staff writer at Buy Side. He specializes in translating complex consumer and ...
For the first time, Broward Health and Memorial Healthcare System will jointly venture into the volatile and potentially lucrative Affordable Care Act marketplace by launching their own insurer for ...